of consumers said clear labeling around how cannabis is treated would impact their purchasing decisions.
0%
associate cannabis decontamination with removing harmful contaminants, and 47.2% associate the term with safety and quality control.
0%
associated decontamination with chemicals, and 10% associated it with radiation.
The assumptions are over. XRpure’s national 2026 consumer survey proves transparency about decontamination builds loyalty, strengthens trust, and positions cannabis brands for success.
This report details how consumers view decontamination, how expectations differ between medical and adult-use consumers, and how transparency is becoming a key driver of purchasing decisions.
If you work in cultivation, QA, or brand management, this data offers a strategic advantage.
Download the 2026 Consumer Survey
Who This Is For
Cultivation leaders, QA teams, brand managers, and executives who need reliable data on consumer perceptions around decontamination and product safety.
What’s Inside
11 pages of consumer data and analysis
Medical vs. adult-use breakdowns
Survey charts and key findings
Clear insights on trust, transparency, and purchase intent